ArticleBreast cancer research : BCR2024

UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabilizing KLF5.

Juan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.